Moreover, in the MC38 model, the concurrent administration of compound 9 with an anti-PD-L1 monoclonal antibody synergistically suppressed tumor growth, leading to the elimination of tumors in nine out of ten treated mice. The gene discussed is CD274; the disease is neoplasm.